Duchenne Muscular Dystrophy News

Russia-Based Circle of Kindness Foundation Announces 18% Price Cut for Elevidys Gene Therapy

Press Releases DMD Warrior -

According to the Foundation's press office, "as a result of the negotiations, the price of one of the most...

Satellos Prepares to Launch Phase 2 Clinical Study of SAT-3247 for the Treatment of Duchenne Muscular Dystrophy

Research DMD Warrior -

Satellos Bioscience, a clinical-stage biotechnology company focused on developing regenerative therapies for muscle diseases, has announced at ClinicalTrials.Gov it...

Del-zota (EXPLORE44) Provides Nearly 30% Normal Dystrophin Production in Patients Amenable to Exon 44 Skipping

Editorials DMD Warrior -

A phase 1/2 EXPLORE44 study (NCT05670730) is now being conducted to evaluate Del-zota, which was developed with the intention...

Belief BioMed BBM-D101 Gene Therapy Receives IND Clearance by National Medical Products Administration (NMPA)

Press Releases DMD Warrior -

Dr. Aravindhan Veerapandiyan, a neurologist at Arkansas Children’s Hospital, Reviews RGX-202 Gene Therapy Study

Editorials DMD Warrior -

Givinostat EMA Approval: When Will Givinostat (Duvyzat) Be Approved in Europe?

Editorials DMD Warrior -

Satellos SAT-3247 Stem Cell Approach May Restore Muscle Regeneration in Duchenne Muscular Dystrophy

Editorials DMD Warrior -

About us

We do not want children to die from a disease that can be cured. We want to give hope to families and ensure that all children with DMD are treated and regain their health.